Logo image of NVRI

ENVIRI CORP (NVRI) Stock Fundamental Analysis

NYSE:NVRI - New York Stock Exchange, Inc. - US4158641070 - Common Stock - Currency: USD

6.965  -0.29 (-3.93%)

Fundamental Rating

2

Overall NVRI gets a fundamental rating of 2 out of 10. We evaluated NVRI against 84 industry peers in the Commercial Services & Supplies industry. NVRI may be in some trouble as it scores bad on both profitability and health. NVRI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year NVRI has reported negative net income.
NVRI had a positive operating cash flow in the past year.
In the past 5 years NVRI always reported negative net income.
Of the past 5 years NVRI 4 years had a positive operating cash flow.
NVRI Yearly Net Income VS EBIT VS OCF VS FCFNVRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M 400M

1.2 Ratios

NVRI has a worse Return On Assets (-3.54%) than 68.29% of its industry peers.
NVRI has a worse Return On Equity (-20.47%) than 73.17% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.80%, NVRI is in line with its industry, outperforming 46.34% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NVRI is significantly below the industry average of 10.12%.
The last Return On Invested Capital (4.80%) for NVRI is above the 3 year average (3.17%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -3.54%
ROE -20.47%
ROIC 4.8%
ROA(3y)-3.19%
ROA(5y)2.17%
ROE(3y)-16.17%
ROE(5y)3.09%
ROIC(3y)3.17%
ROIC(5y)2.89%
NVRI Yearly ROA, ROE, ROICNVRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

NVRI's Operating Margin of 5.77% is in line compared to the rest of the industry. NVRI outperforms 48.78% of its industry peers.
NVRI's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 20.84%, NVRI is doing worse than 70.73% of the companies in the same industry.
NVRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.77%
PM (TTM) N/A
GM 20.84%
OM growth 3Y17.6%
OM growth 5Y-9.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.45%
GM growth 5Y-3.28%
NVRI Yearly Profit, Operating, Gross MarginsNVRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 20 30 40

More info and screens

2

2. Health

2.1 Basic Checks

NVRI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for NVRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NVRI Yearly Shares OutstandingNVRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M
NVRI Yearly Total Debt VS Total AssetsNVRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 1.95 indicates that NVRI is not a great score, but indicates only limited risk for bankruptcy at the moment.
NVRI has a Altman-Z score of 1.95. This is comparable to the rest of the industry: NVRI outperforms 47.56% of its industry peers.
NVRI has a Debt/Equity ratio of 2.99. This is a high value indicating a heavy dependency on external financing.
NVRI's Debt to Equity ratio of 2.99 is on the low side compared to the rest of the industry. NVRI is outperformed by 87.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF N/A
Altman-Z 1.95
ROIC/WACC0.58
WACC8.33%
NVRI Yearly LT Debt VS Equity VS FCFNVRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B

2.3 Liquidity

A Current Ratio of 1.30 indicates that NVRI should not have too much problems paying its short term obligations.
With a Current ratio value of 1.30, NVRI is not doing good in the industry: 63.41% of the companies in the same industry are doing better.
NVRI has a Quick Ratio of 1.30. This is a bad value and indicates that NVRI is not financially healthy enough and could expect problems in meeting its short term obligations.
NVRI's Quick ratio of 0.99 is on the low side compared to the rest of the industry. NVRI is outperformed by 67.07% of its industry peers.
Industry RankSector Rank
Current Ratio 1.3
Quick Ratio 0.99
NVRI Yearly Current Assets VS Current LiabilitesNVRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

More info and screens

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 50.00% over the past year.
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.65%

3.2 Future

NVRI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 213.37% yearly.
NVRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.95% yearly.
EPS Next Y336.73%
EPS Next 2Y213.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-0.04%
Revenue Next 2Y1.71%
Revenue Next 3Y2.72%
Revenue Next 5Y2.95%

3.3 Evolution

NVRI Yearly Revenue VS EstimatesNVRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
NVRI Yearly EPS VS EstimatesNVRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 0.5 1

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVRI. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 49.04, the valuation of NVRI can be described as expensive.
The rest of the industry has a similar Price/Forward Earnings ratio as NVRI.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, NVRI is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 49.04
NVRI Price Earnings VS Forward Price EarningsNVRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100

4.2 Price Multiples

86.59% of the companies in the same industry are more expensive than NVRI, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.13
NVRI Per share dataNVRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NVRI's earnings are expected to grow with 213.37% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y213.37%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NVRI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ENVIRI CORP

NYSE:NVRI (2/24/2025, 3:05:40 PM)

6.965

-0.29 (-3.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-20 2025-02-20/bmo
Earnings (Next)04-30 2025-04-30/bmo
Inst Owners96.26%
Inst Owner ChangeN/A
Ins Owners2.82%
Ins Owner Change1.79%
Market Cap558.18M
Analysts80
Price Target15.05 (116.08%)
Short Float %4.13%
Short Ratio3.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)188.54%
Min EPS beat(2)-115.08%
Max EPS beat(2)492.16%
EPS beat(4)3
Avg EPS beat(4)113.18%
Min EPS beat(4)-115.08%
Max EPS beat(4)492.16%
EPS beat(8)7
Avg EPS beat(8)125%
EPS beat(12)10
Avg EPS beat(12)125.94%
EPS beat(16)13
Avg EPS beat(16)112.85%
Revenue beat(2)0
Avg Revenue beat(2)-5.71%
Min Revenue beat(2)-8.35%
Max Revenue beat(2)-3.06%
Revenue beat(4)2
Avg Revenue beat(4)2.45%
Min Revenue beat(4)-8.35%
Max Revenue beat(4)15.47%
Revenue beat(8)5
Avg Revenue beat(8)2.45%
Revenue beat(12)7
Avg Revenue beat(12)-2.85%
Revenue beat(16)7
Avg Revenue beat(16)-9.54%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-2.17%
EPS NY rev (3m)-2.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-0.04%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 49.04
P/S 0.24
P/FCF N/A
P/OCF 5.07
P/B 1.15
P/tB N/A
EV/EBITDA 6.13
EPS(TTM)-0.06
EYN/A
EPS(NY)0.14
Fwd EY2.04%
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)1.37
OCFY19.71%
SpS28.86
BVpS6.04
TBVpS-7.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.54%
ROE -20.47%
ROCE 6.11%
ROIC 4.8%
ROICexc 5.05%
ROICexgc 10.39%
OM 5.77%
PM (TTM) N/A
GM 20.84%
FCFM N/A
ROA(3y)-3.19%
ROA(5y)2.17%
ROE(3y)-16.17%
ROE(5y)3.09%
ROIC(3y)3.17%
ROIC(5y)2.89%
ROICexc(3y)3.31%
ROICexc(5y)3.01%
ROICexgc(3y)7.02%
ROICexgc(5y)6.53%
ROCE(3y)4.03%
ROCE(5y)3.67%
ROICexcg growth 3Y31.88%
ROICexcg growth 5Y-8.13%
ROICexc growth 3Y35.75%
ROICexc growth 5Y-11.99%
OM growth 3Y17.6%
OM growth 5Y-9.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.45%
GM growth 5Y-3.28%
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 2.99
Debt/FCF N/A
Debt/EBITDA 4.62
Cap/Depr 82.71%
Cap/Sales 6.43%
Interest Coverage 250
Cash Conversion 35.13%
Profit Quality N/A
Current Ratio 1.3
Quick Ratio 0.99
Altman-Z 1.95
F-Score4
WACC8.33%
ROIC/WACC0.58
Cap/Depr(3y)86.83%
Cap/Depr(5y)94.11%
Cap/Sales(3y)7.53%
Cap/Sales(5y)9.18%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%42.86%
EPS Next Y336.73%
EPS Next 2Y213.37%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%5.65%
Revenue Next Year-0.04%
Revenue Next 2Y1.71%
Revenue Next 3Y2.72%
Revenue Next 5Y2.95%
EBIT growth 1Y15.72%
EBIT growth 3Y29.94%
EBIT growth 5Y-0.99%
EBIT Next Year229.28%
EBIT Next 3Y54.47%
EBIT Next 5Y30.91%
FCF growth 1Y-755.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-29.75%
OCF growth 3Y28.61%
OCF growth 5Y-9.83%